Cytokinetics | CYTK - Interest Expense On Debt


Cytokinetics reported $33.34M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
Amgen USD 95.64B 94.98B Jun/2026
Arca Biopharma USD 4.6M 4.1M Mar/2026
Bayer EUR 675M 87M Dec/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 407M 4M Jun/2026
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cytokinetics USD 33.34M 3M Mar/2026
Eisai JPY 1.96B 409M Jun/2026
Eli Lilly USD 114.7M 134.3M Sep/2025
Exelixis USD 23.4M 3.9M Sep/2023
Geron USD 7.15M 150K Mar/2026
Halozyme Therapeutics USD 5.51M 597K Mar/2026
Ionis Pharmaceuticals USD 18M 1000K Jun/2026
Ligand Pharmaceuticals USD 1.78M 875K Dec/2025
Merck USD 525M 46M Jun/2026
Novartis USD 462M 119M Jun/2026
Pfizer USD 667M 4M Jun/2026
Regeneron Pharmaceuticals USD 11M 1.9M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 287M 109M Jun/2026